tiprankstipranks
Alcon (CH:ALC)
NYSE:ALC
Switzerland Market
Want to see CH:ALC full AI Analyst Report?

Alcon (ALC) Stock Forecast & Price Target

18 Followers
See the Price Targets and Ratings of:

ALC Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
8 Buy
2 Hold
1 Sell
Based on 11 analysts giving stock ratings to
Alcon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALC Stock 12 Month Forecast

Average Price Target

CHF71.84
▲(28.89% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is CHF71.84 with a high forecast of CHF85.00 and a low forecast of CHF48.00. The average price target represents a 28.89% change from the last price of CHF55.74.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"47":"CHF47","86":"CHF86","56.75":"CHF56.8","66.5":"CHF66.5","76.25":"CHF76.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF85.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71.8417407398,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF71.84</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF48.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[47,56.75,66.5,76.25,86],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,57.65846153846154,59.93692307692308,62.215384615384615,64.49384615384615,66.77230769230769,69.05076923076923,71.32923076923078,73.6076923076923,75.88615384615385,78.16461538461539,80.44307692307692,82.72153846153846,{"y":85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,56.64628774921539,57.91257549843077,59.178863247646156,60.44515099686154,61.71143874607692,62.97772649529231,64.2440142445077,65.51030199372308,66.77658974293847,68.04287749215385,69.30916524136923,70.57545299058462,{"y":71.8417407398,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,54.8123076923077,54.244615384615386,53.67692307692308,53.10923076923077,52.541538461538465,51.973846153846154,51.40615384615385,50.83846153846154,50.27076923076923,49.70307692307692,49.135384615384616,48.567692307692305,{"y":48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.472,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.71,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.132,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.431,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.974,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.024,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.789,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.938,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.72,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.78,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.38,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF85.00Average Price TargetCHF71.84Lowest Price TargetCHF48.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank  Analyst forecast on CH:ALC
Deutsche Bank
Deutsche Bank
CHF70CHF73
Buy
30.97%
Upside
Reiterated
08/17/26
Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank
UBS
CHF86CHF83
Buy
48.91%
Upside
Reiterated
08/14/26
Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)
Mizuho Securities Analyst forecast on CH:ALC
Mizuho Securities
Mizuho Securities
CHF67.92
Buy
21.85%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)
William Blair Analyst forecast on CH:ALC
William Blair
William Blair
Hold
Assigned
08/12/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)
J.P. Morgan Analyst forecast on CH:ALC
J.P. Morgan
J.P. Morgan
CHF62.65
Hold
12.39%
Upside
Reiterated
08/12/26
J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)
Needham
CHF75.91CHF78.31
Buy
40.49%
Upside
Reiterated
08/11/26
Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers
Berenberg Bank Analyst forecast on CH:ALC
Berenberg Bank
Berenberg Bank
CHF85
Buy
52.49%
Upside
Reiterated
08/07/26
Berenberg Bank Keeps Their Buy Rating on Alcon (ALC)
Bank of America Securities Analyst forecast on CH:ALC
Bank of America Securities
Bank of America Securities
CHF50CHF48
Sell
-13.89%
Downside
Reiterated
07/21/26
Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48
Argus Research Analyst forecast on CH:ALC
Argus Research
Argus Research
CHF67.92
Buy
21.85%
Upside
Reiterated
07/01/26
Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus
KeyBanc
CHF70.32
Buy
26.15%
Upside
Reiterated
06/12/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)
Citi
CHF89.5CHF82.3
Buy
47.66%
Upside
Reiterated
06/11/26
Alcon (ALC) Gets a Buy from Citi
Stifel Nicolaus Analyst forecast on CH:ALC
Stifel Nicolaus
Stifel Nicolaus
CHF55.93
Hold
0.35%
Upside
Reiterated
05/21/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)
Robert W. Baird Analyst forecast on CH:ALC
Robert W. Baird
Robert W. Baird
CHF78.31CHF71.92
Buy
29.02%
Upside
Reiterated
05/07/26
Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird
Barclays Analyst forecast on CH:ALC
Barclays
Barclays
CHF62.33
Hold
11.82%
Upside
Reiterated
05/06/26
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)
RBC Capital
CHF80
Buy
43.52%
Upside
Reiterated
05/06/26
Alcon (ALC) Gets a Buy from RBC Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank  Analyst forecast on CH:ALC
Deutsche Bank
Deutsche Bank
CHF70CHF73
Buy
30.97%
Upside
Reiterated
08/17/26
Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank
UBS
CHF86CHF83
Buy
48.91%
Upside
Reiterated
08/14/26
Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)
Mizuho Securities Analyst forecast on CH:ALC
Mizuho Securities
Mizuho Securities
CHF67.92
Buy
21.85%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)
William Blair Analyst forecast on CH:ALC
William Blair
William Blair
Hold
Assigned
08/12/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)
J.P. Morgan Analyst forecast on CH:ALC
J.P. Morgan
J.P. Morgan
CHF62.65
Hold
12.39%
Upside
Reiterated
08/12/26
J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)
Needham
CHF75.91CHF78.31
Buy
40.49%
Upside
Reiterated
08/11/26
Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers
Berenberg Bank Analyst forecast on CH:ALC
Berenberg Bank
Berenberg Bank
CHF85
Buy
52.49%
Upside
Reiterated
08/07/26
Berenberg Bank Keeps Their Buy Rating on Alcon (ALC)
Bank of America Securities Analyst forecast on CH:ALC
Bank of America Securities
Bank of America Securities
CHF50CHF48
Sell
-13.89%
Downside
Reiterated
07/21/26
Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48
Argus Research Analyst forecast on CH:ALC
Argus Research
Argus Research
CHF67.92
Buy
21.85%
Upside
Reiterated
07/01/26
Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus
KeyBanc
CHF70.32
Buy
26.15%
Upside
Reiterated
06/12/26
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)
Citi
CHF89.5CHF82.3
Buy
47.66%
Upside
Reiterated
06/11/26
Alcon (ALC) Gets a Buy from Citi
Stifel Nicolaus Analyst forecast on CH:ALC
Stifel Nicolaus
Stifel Nicolaus
CHF55.93
Hold
0.35%
Upside
Reiterated
05/21/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)
Robert W. Baird Analyst forecast on CH:ALC
Robert W. Baird
Robert W. Baird
CHF78.31CHF71.92
Buy
29.02%
Upside
Reiterated
05/07/26
Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird
Barclays Analyst forecast on CH:ALC
Barclays
Barclays
CHF62.33
Hold
11.82%
Upside
Reiterated
05/06/26
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)
RBC Capital
CHF80
Buy
43.52%
Upside
Reiterated
05/06/26
Alcon (ALC) Gets a Buy from RBC Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alcon

3 Months
Larry BiegelsenWells Fargo
Success Rate
13/19 ratings generated profit
68%
Average Return
+2.04%
Copying Larry Biegelsen's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +2.04% per trade.
1 Year
Larry BiegelsenWells Fargo
Success Rate
12/19 ratings generated profit
63%
Average Return
+4.57%
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +4.57% per trade.
2 Years
Anthony PetroneMizuho Securities
Success Rate
13/24 ratings generated profit
54%
Average Return
+4.37%
Copying Anthony Petrone's trades and holding each position for 2 Years would result in 54.17% of your transactions generating a profit, with an average return of +4.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALC Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
3
4
5
2
Buy
18
15
8
7
8
Hold
5
7
5
4
2
Sell
3
3
2
2
1
Strong Sell
0
0
0
0
0
total
26
28
19
18
13
In the current month, ALC has received 10 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. ALC average Analyst price target in the past 3 months is 71.84.
Each month's total comprises the sum of three months' worth of ratings.

ALC Financial Forecast

ALC Earnings Forecast

Next quarter’s earnings estimate for ALC is CHF0.71 with a range of CHF0.67 to CHF0.75. The previous quarter’s EPS was CHF0.68. ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALC is CHF0.71 with a range of CHF0.67 to CHF0.75. The previous quarter’s EPS was CHF0.68. ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Sales Forecast

Next quarter’s sales forecast for ALC is CHF2.22B with a range of CHF2.20B to CHF2.25B. The previous quarter’s sales results were CHF2.23B. ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.
Next quarter’s sales forecast for ALC is CHF2.22B with a range of CHF2.20B to CHF2.25B. The previous quarter’s sales results were CHF2.23B. ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Stock Forecast FAQ

What is CH:ALC’s average 12-month price target, according to analysts?
Based on analyst ratings, Alcon’s 12-month average price target is 71.84.
    What is CH:ALC’s upside potential, based on the analysts’ average price target?
    Alcon has 28.89% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Alcon a Buy, Sell or Hold?
          Alcon has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 2 hold ratings and 1 sell ratings.
            What is Alcon’s share price target?
            The average share price target for Alcon is 71.84. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF85.00 ,and the lowest forecast is CHF48.00. The average share price target represents 28.89% Increase from the current price of CHF55.74.
              What do analysts say about Alcon?
              Alcon’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Alcon?
                To buy shares of CH:ALC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.